Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enhancing the efficacy of tDCS by nicotinergic stimulation in schizophrenia
DRKS00013260Phase 2Completed
- Sponsor
- LMU Klinikum
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of varenicline in schizophrenia (4 arms), sponsored by LMU Klinikum. Started Dec 2017; status: completed.
02
Drugs
varenicline
03
Conditions
schizophrenia
Beyond the preview
Go deeper on DRKS00013260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00013260.